New Targeted Therapies and Immunotherapies for Locally Advanced Periocular Malignant Tumours: Towards a New ‘Eye-Sparing’ Paradigm?
Arnaud Martel(Université de Sherbrooke), Stéphanie Baillif(Université Côte d'Azur), Lauris Gastaud(Leiden University Medical Center), Corine Bertolotto(Centre Méditerranéen de Médecine Moléculaire), Sandra Lassalle(Université Côte d'Azur), Alexandra Picard‐Gauci(Université Côte d'Azur), Sacha Nahon‐Estève(Université Côte d'Azur), Paul Hofman(Inserm), G. Poissonnet, Henri Montaudié(Hôpital l'Archet)
Cited by 20
Related Papers
Targeting Cancer Cell Metabolism: The Combination of Metformin and 2-Deoxyglucose Induces p53-Dependent Apoptosis in Prostate Cancer Cells
|Cancer Research|2010|528
The Extracellular Signal–Regulated Kinase Isoform ERK1 Is Specifically Required for In Vitro and In Vivo Adipogenesis
|Diabetes|2005|334
Selumetinib in Combination With Dacarbazine in Patients With Metastatic Uveal Melanoma: A Phase III, Multicenter, Randomized Trial (SUMIT)
|Journal of Clinical Oncology|2018|274
Senescent cells develop a PARP-1 and nuclear factor-κB-associated secretome (PNAS)
|Genes & Development|2011|259